Document is current
Any future updates will be listed below
-
Authors
Carvalho, Laura Machado Lara
Rzasa, Jessica
Kerkhof, Jennifer
McConkey, Haley
Fishman, Veniamin
Koksharova, Galina
de Lima Jorge, Alexander Augusto
Branco, Elisa Varella
de Oliveira, Danyllo Felipe
Martinez-Delgado, Beatriz
Barrero, Maria J.
Kleefstra, Tjitske
Sadikovic, Bekim
Haddad, Luciana Amaral
Bertola, Débora Romeo
Rosenberg, Carla
Krepischi, Ana Cristina Victorino
-
Funding
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2022/03980-5, 2020/13355-5, 2013/08028-1, 2013/08028-1, 2013/08028-1)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (305806/2019-0)
- License Information
-
More Information
Article History
Received: 6 May 2024
Accepted: 2 December 2024
First Online: 15 December 2024
Declarations
:
: This research is in accordance with ethical standards established in the Declaration of Helsinki (1964), its subsequent revisions, and Resolution 466/2012 of the Brazilian National Health Council. The project was approved by the Research Ethics Committee of the Biosciences Institute of the University of São Paulo (80921117.5.0000.5464). Informed consent was obtained from the patient’s mothers, who also authorized the publication of photographs and clinical and molecular data.
: BS is a shareholder in EpiSign Inc., a biotechnology company involved in the commercialization of EpiSign™ technology.
